Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers stock gains risking short squeeze (HIMS:NYSE)

Hims & Hers Health (NYSE:HIMS) stock spikes, risking a short squeeze given its elevated short interest. Read more here.…

Why Hims & Hers Health, Inc. (HIMS) Went Up On Friday

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to…

Why Hims & Hers Health, Inc. (HIMS) Went Up On Friday

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take…

Hims & Hers Health (HIMS) Stock Surges 10%: Whats Behind the Rally?

Hims & Hers Health, Inc. (HIMS) has experienced a significant stock price increase of 10% today, reaching $40.25 per share.…

Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings?

The continued solid uptake of Hims & Hers offerings and expanding subscriber base are likely to have driven the companys…

Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings?

The continued solid uptake of Hims & Hers offerings and expanding subscriber base are likely to have driven the companys…

Why Hims & Hers Health, Inc. (HIMS) Soared On Thursday

We recently published a list of 10 Firms Lead Rally on Impressive Q1 Earnings, Optimistic Outlooks. In this article, we…

Hims & Hers Health, Inc. (HIMS) May 9 weekly 36.50 straddle priced into quarter results

Hims & Hers Health, Inc. (NYSE: HIMS) May 9 weekly 36.50 straddle priced for movement of 19% into the expected…

Hims & Hers Health (NYSE:HIMS) Surges 24% In One Week After Novo Nordisk Partnership

Hims & Hers Health (NYSE:HIMS) recently announced a partnership with Novo Nordisk to enhance obesity care access in the U.S.,…

Hims & Hers Health (NYSE:HIMS) Surges 24% In One Week After Novo Nordisk Partnership

Hims & Hers Health (NYSE:HIMS) recently announced a partnership with Novo Nordisk to enhance obesity care access in the U.S.,…

Hims & Hers: Revolutionizing Healthcare

…

Hims & Hers: Revolutionizing Healthcare (NYSE:HIMS)

Hims & Hers is an increasingly profitable, vertically integrated telehealth platform with major tailwinds, positioning it as a long-term healthcare…

How To Trade Hims & Hers Health Stock Ahead of Its Earnings?

Hims & Hers Health (NYSE:HIMS) is scheduled to release its earnings report on Monday, May 5, 2025. Historically, the stock…

Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily…

Cautious Hold Rating on Hims & Hers Health Amid Strategic Partnership with Novo Nordisk

Leerink Partners analyst Michael Cherny maintained a Hold rating on Hims & Hers Health (HIMS – Research Report) on April…

Hims & Hers Health Insider Sold Shares Worth $3,077,070, According to a Recent SEC Filing

Andrew Dudum, 10% Owner, Director, Chief Executive Officer, on April 28, 2025, sold 91,667 shares in Hims & Hers Health…

Why Hims & Hers Health, Inc. (HIMS) Soared on Tuesday

We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take a…

Why Hims & Hers Health, Inc. (HIMS) Soared on Tuesday

We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take…

Why Hims & Hers Health, Inc. (HIMS) Soared on Tuesday

We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take…

Bank of America Weighs In on Hims & Hers Health Stock Following Novo Nordisk Tie-Up

Hims Hers Health (NYSE:HIMS) stock has been one of the market’s strongest performers this year. Even after pulling back…

Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy

Americans with a prescription will have access to Novo Nordisks obesity drug Wegovy through the Hims & Hers platform for…

Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?

Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their…

Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?

Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their…

Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space. This is…

Should you buy Hims and Hers stock? (May 2024)

Published first at Hims and Hers stock analysis. Ticker: $HIMS Telehealth company HIMS reported earnings last week and the stock…

Hims & Hers Stock Soars on Novo Nordisk Collaboration

Hims & Hers stock rallies by over 25% on news of a collaboration with Novo Nordisk and its weight loss…

Hims & Hers Health (HIMS) Stock: Weight Loss Drug Deal Sends Shares Soaring

Hims & Hers stock jumps 23% after partnering with Novo Nordisk to sell Wegovy weight-loss drug for $599 monthly on…

Hims & Hers Aktie: Kooperation mit Novo Nordisk bringt Wegovy auf die Plattform

Charlotte (www.aktiencheck.de) - Hims & Hers-Aktienanalyse von BofA Securities: Rating und Kursziel BofA Securities hat das Kursziel für Hims & Hers Health…

Hims & Hers Health Aktie: Strategische Partnerschaft mit Novo Nordisk

New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Needham & Co: 1. Strategische Partnerschaft mit Novo Nordisk Hims & Hers Health…

Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar?

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings…

Up 30% In A Week, HIMS Stock Is Just Getting Warmed Up

Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer…

Novo Nordisk Forms GLP-1 Partnership with Hims & Hers

Hims & Hers is now offering discounted access to Wegovy, a GLP-1 manufactured by Novo Nordisk, on its platform.…

Hims & Hers Health In Spotlight, Soared 23% Tuesday. Build Your Growth Stocks Watchlist With These Just Updated Screens.

Hims & Hers Health stock popped 23% to 35.04 Tuesday. It hit an all-time high on Feb. 19. Hims was…

Hims & Hers and other telehealth providers to start selling Wegovy

Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers.…

Hims & Hers, LifeMD stock skyrockets after inking deal with Novo Nordisk to sell Wegovy

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy. |…

Novo Nordisk, Hims & Hers partner to sell Wegovy

The telehealth provider has sold compounded versions of Novo’s GLP-1 since 2022.…

Hims & Hers Health: GLP-1 Deals De-Risk The Story

…

Hims & Hers Health: GLP-1 Deals De-Risk The Story (NYSE:HIMS)

Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ultra-bullish…

Why Hims & Hers Health and LifeMD Are Skyrocketing Today

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after…

Hims & Hers Health (HIMS) Shares Skyrocket, What You Need To Know

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk announced plans…

Hims & Hers Joins Forces With Novo Nordisk

Hims & Hers and Novo Nordisk are teaming to expand affordable access to weight loss treatments, launching a bundled Wegovy…

Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform - Hims & Hers Health (NYSE:HIMS), Novo Nordisk (NYSE:NVO)

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care…

dpa-AFX ProFeed